| Rivaroxaban with or without aspirin in stable cardiovascular disease JW Eikelboom, SJ Connolly, J Bosch, GR Dagenais, RG Hart, ... New England Journal of Medicine 377 (14), 1319-1330, 2017 | 2423 | 2017 |
| Safety of Proton Pump Inhibitors Based on a Large, Multi-year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin. C investigators. Gastroenterology, 2019 | 428 | 2019 |
| Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial SJ Connolly, JW Eikelboom, J Bosch, G Dagenais, L Dyal, F Lanas, ... The Lancet 391 (10117), 205-218, 2018 | 405 | 2018 |
| Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a … Lancet, 2020 | 283 | 2020 |
| Rationale, design and baseline characteristics of participants in the cardiovascular outcomes for people using anticoagulation strategies (COMPASS) trial J Bosch, JW Eikelboom, SJ Connolly, NC Bruns, V Lanius, F Yuan, ... Canadian Journal of Cardiology 33 (8), 1027-1035, 2017 | 200 | 2017 |
| Obesity and preeclampsia: common pathophysiological mechanisms P Lopez-Jaramillo, J Barajas, SM Rueda-Quijano, C Lopez-Lopez, ... Frontiers in physiology 9, 1838, 2018 | 195 | 2018 |
| Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial. C investigators. Gastroenterology, 2019 | 168 | 2019 |
| Family-led rehabilitation after stroke in India (ATTEND): a randomised controlled trial RI Lindley, CS Anderson, L Billot, A Forster, ML Hackett, LA Harvey, S Jan, ... The Lancet 390 (10094), 588-599, 2017 | 132 | 2017 |
| Dietary calcium supplementation and prevention of pregnancy hypertension P Lopez-Jaramillo, M Narvaez, C Felix, A Lopez The Lancet 335 (8684), 293, 1990 | 129 | 1990 |
| Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease: Insights From the COMPASS Trial Circulation, 1841–1854, 2020 | 114 | 2020 |
| COMPASS investigators. Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial SJ Connolly, JW Eikelboom, J Bosch, G Dagenais, L Dyal, F Lanas, ... Lancet 391 (10117), 205-218, 2018 | 110 | 2018 |
| Prenatal diet, nutrient intake and pregnancy outcome in urban Ecuadorian primiparas. MM Weigel, WM Nárváez, A López, C Félix, P López Archivos Latinoamericanos de Nutrición 41 (1), 21-37, 1991 | 56 | 1991 |
| Bleeding and new cancer diagnosis in patients with atherosclerosis JW Eikelboom, SJ Connolly, J Bosch, O Shestakovska, V Aboyans, ... Circulation 140 (18), 1451-1459, 2019 | 47 | 2019 |
| Mortality benefit of rivaroxaban plus aspirin in patients with chronic coronary or peripheral artery disease JW Eikelboom, DL Bhatt, KAA Fox, J Bosch, SJ Connolly, SS Anand, ... Journal of the American College of Cardiology 78 (1), 14-23, 2021 | 46 | 2021 |
| Skeletonized vs pedicled internal mammary artery graft harvesting in coronary artery bypass surgery: a post hoc analysis from the COMPASS trial A Lamy, A Browne, T Sheth, Z Zheng, F Dagenais, N Noiseux, X Chen, ... JAMA cardiology 6 (9), 1042-1049, 2021 | 41 | 2021 |
| Prevalence of metabolic syndrome and diabetes mellitus type-2 and their association with intake of dairy and legume in Andean communities of Ecuador ME Baldeón, C Felix, M Fornasini, F Zertuche, C Largo, MJ Paucar, ... PloS One 16 (7), e0254812, 2021 | 27 | 2021 |
| Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial JW Eikelboom, SS Jolly, EP Belley-Cote, RP Whitlock, S Rangarajan, ... The Lancet Respiratory Medicine 10 (12), 1169-1177, 2022 | 23 | 2022 |
| Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial JW Eikelboom, SS Jolly, EP Belley-Cote, RP Whitlock, S Rangarajan, ... The Lancet Respiratory Medicine 10 (12), 1160-1168, 2022 | 18 | 2022 |
| Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of … European Heart Journal Cardiovascular Pharmacotherapy, 2022 | 18 | 2022 |
| Prevalencia de parásitos intestinales y comparación de dos méto-dos diagnósticos en heces de niños escolares de tres parroquias del Distrito Metropolitano de Quito, provincia … F Oña-Cisneros, D García, MA Costta, K Benavides, W Villafuerte, ... Revista Eugenio Espejo 4 (5), 9-14, 2015 | 17 | 2015 |
PATRICIO LOPEZ -JARAMILLOScientific Director Masira Research Institute, UDES,Bucaramanga,Colombia,Vist Prof, UTE,Ecuador在 ute.edu.ec 的电子邮件经过验证
